Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
20 October 2023 | Story Samkelo Fetile
2023 UFS Thought-Leader Webinar Series

The University of the Free State (UFS) is pleased to present a panel discussion titled, Student protest action, politics, and higher education, which is part of the 2023 Thought-Leader Webinar Series. Join Prof Adam Habib and Dr Max Price for a discussion about their respective experiences in leadership positions during the #RhodesMustFall and #FeesMustFall student protest movements, the lessons learnt during these tumultuous times, and how these events continue to influence the current landscape in the higher education sector in South Africa and further afield. The discussion will reflect on their recent books Rebels and Rage: Reflecting on #FeesMustFall, and Statues and Storms, and will be facilitated by Prof Francis Petersen, the Vice-Chancellor and Principal of the UFS.


Date:   Tuesday 21 November 2023

Time: 13:00-14:30

Click to view document WATCH: vimeo.com/kovsies/tls23

For further information, contact Alicia Pienaar at pienaaran1@ufs.ac.za.


Some of the topics discussed by leading experts in 2022 included, Crime in South Africa – who is to blame; Are our glasses half full or half empty; What needs to be done to power up South Africa; A look into the future of South Africa. This year’s webinar series commenced with a discussion on Threats to South Africa’s stability and security challenges, followed by A culture of acceptance – is this South Africa’s greatest threat? and The need for a global and regional plan / approach to respond to the consequences of the Russia-Ukraine war.


Facilitator:

Prof Francis Petersen

Vice-Chancellor and Principal, UFS

 

Panellists:

Prof Adam Habib

Director: School of Oriental and African Studies, University of London

 

Dr Max Price

Emeritus Vice-Chancellor, University of Cape Town; academic and consultant

 

Bios of speakers:

 

Prof Adam Habib

Prof Adam Habib is an academic, researcher, activist, administrator, and well-known public intellectual. A Professor of Political Science, Prof Habib has more than 30 years of academic, research, and administration expertise, spanning five universities and multiple local and international institutions.

Prior to his appointment as Director of SOAS, he was Vice-Chancellor and Principal of the University of the Witwatersrand (Wits) in Johannesburg, South Africa between 2013 and 2020. He has also served as Deputy Vice-Chancellor of Research at the University of Johannesburg, Executive Director of Democracy and Governance at the Human Sciences Research Council, and as Director of the Centre for Civil Society and Professor of Development at the University of KwaZulu-Natal. He is widely published, including his two well-received monographs, South Africa's Suspended Revolution: Hopes and Prospects and Rebels and Rage: Reflecting on #FeesMustFall.

Prof Habib’s academic contributions resulted in his election to the American Academy of Arts and Sciences, in addition to serving as a fellow of both the African Academy of Sciences and the Academy of Science of South Africa. He also serves on the Council of the United Nations University.

 

Dr Max Price

Dr Max Price was appointed Vice-Chancellor of the University of Cape Town in July 2008, completing his ten-year term in June 2018. During the first seven years of his term, UCT experienced growth and success in research and teaching, as well as global recognition. This continued during the last three years but was overshadowed by the Rhodes Must Fall and Fees Must Fall protests during 2015 to 2017. Dr Price led the university through these storms and back to safe harbour in 2018.

Dr Price studied Medicine at the University of the Witwatersrand (Wits), during which time he became deeply involved in student politics, becoming SRC president a year after the Soweto uprising. He subsequently did a PPE degree at Oxford as a Rhodes Scholar. Following clinical work in academic and rural hospitals in South Africa, he gained a master’s degree in Community Health at the London School of Hygiene and Tropical Medicine, and then worked as an academic in the areas of health policy and economics, rural health services, and health science education.

He was dean of the Faculty of Health Sciences at Wits for ten years. He now consults in public health, higher education, strategic leadership, and advises foundations on grant making. He is currently a scholar in residence at the Atlantic Institute. He is the author of Statues and Storms: Leading through change, published in 2023.

News Archive

UFS to monitor the use of ARV-drugs on pregnant women and children
2004-12-08

The University of the Free State (UFS) is to establish a Pharmacovigilance Centre that will monitor the effects of Anti-Retroviral (ARV) drugs on HIV positive pregnant women and children starting early in the new year.

The UFS is one of only two institutions chosen by the Minister of Health, Dr Manto Tshabalala-Msimang, to establish such an ARV monitoring centre.

The other centre will be based at Medical University of South Africa (MEDUNSA) and will concentrate mainly on monitoring the effects of the drugs on adults.

“The establishment of the UFS’s Pharmaconvigilance Centre forms part of government’s Comprehensive Plan on HIV and AIDS, often termed the roll-out plan for ARV drugs. The centre’s primary responsibility will be to specifically monitor the use of these drugs in pregnant women, and children under the age of 13,” said Prof Andrew Walubo of the UFS’s Department of Pharmacology.

“Although most of the side effects of ARV drugs have been identified in other countries, it has now become critical to identify the side effects amongst the South African population. This is important because many people will be exposed to the drugs within a short time. Our aim is so identify the most common side effects and make recommendations for the prevention thereof. The centre will help in detecting the risk of using anti-retroviral drugs in pregnancy and children, and prevention of adverse drug reactions,” said Prof Walubo.

According to Prof Walubo 12 drugs will be monitored – these drugs will be selected according to the patient’s profile.

The centre will comprise of two components: A pregnancy registry, which will focus on a new-born child up until two months and a pediatric registry, which will focus on children who are born of mothers who used ARV drugs and children using ARV drugs.

According to Prof Walubo, the Pharmaconvigilance Centre will also be responsible for offering relevant technical advice, training and selected research on ARV drugs in these patients.

The centre will be fully sponsored by the national Department of Health. It will be based in the UFS’s Faculty of Health Sciences, Department of Pharmacology, and will be run in collaboration with experts from different departments in the faculty.

Media release
Issued by: Lacea Loader
Media Representative
Tel: (051) 401-2584
Cell: 083 645 2454
E-mail: loaderl.stg@mail.uovs.ac.za
8 December 2004

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept